Elebsiran and PEG-IFNalpha for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial. (nature.com)

Authors: Wong GL … Hong Z Journal: Nature Medicine Published: 2026-01-01 DOI: https://doi.org/10.1038/s41591-025-04049-z